Gavin Gear
President & CEO Logix Biosciences
Seminars
Thursday 21st May 2026
Intranasal Delivery of a Novel Synthetic Small-Molecule Antibiotic Using Nanocarriers
3:00 pm
- Trace the journey from honey-derived antimicrobial activity to a scalable, water-soluble synthetic small molecule designed for intranasal delivery
- Explore how intranasal administration enables early intervention against viral infections that trigger secondary bacterial disease, with implications for resistance management
- Learn how nanocarrier delivery supports sustained local release, minimizes systemic exposure, and enables safe degradation into non-cytotoxic components after therapeutic action
